Avid Bioservices Statistics
Total Valuation
CDMO has a market cap or net worth of $577.67 million. The enterprise value is $743.13 million.
| Market Cap | 577.67M |
| Enterprise Value | 743.13M |
Important Dates
The next estimated earnings date is Thursday, June 20, 2024, after market close.
| Earnings Date | Jun 20, 2024 |
| Ex-Dividend Date | n/a |
Share Statistics
CDMO has 63.48 million shares outstanding. The number of shares has decreased by -8.45% in one year.
| Shares Outstanding | 63.48M |
| Shares Change (YoY) | -8.45% |
| Shares Change (QoQ) | +0.27% |
| Owned by Insiders (%) | 1.07% |
| Owned by Institutions (%) | 107.15% |
| Float | 55.21M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | 88.50 |
| PS Ratio | 4.23 |
| Forward PS | 3.76 |
| PB Ratio | 3.21 |
| P/FCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 5.43 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 0.47, with a Debt / Equity ratio of 1.08.
| Current Ratio | 0.47 |
| Quick Ratio | 0.22 |
| Debt / Equity | 1.08 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -5.64 |
Financial Efficiency
Return on equity (ROE) is -9.70% and return on invested capital (ROIC) is -4.41%.
| Return on Equity (ROE) | -9.70% |
| Return on Assets (ROA) | -4.00% |
| Return on Capital (ROIC) | -4.41% |
| Revenue Per Employee | $374,616 |
| Profits Per Employee | -$49,271 |
| Employee Count | 365 |
| Asset Turnover | 0.30 |
| Inventory Turnover | 3.18 |
Taxes
| Income Tax | -3.17M |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -40.04% in the last 52 weeks. The beta is 1.56, so CDMO's price volatility has been higher than the market average.
| Beta (1Y) | 1.56 |
| 52-Week Price Change | -40.04% |
| 50-Day Moving Average | 7.24 |
| 200-Day Moving Average | 7.77 |
| Relative Strength Index (RSI) | 68.74 |
| Average Volume (30 Days) | 1,431,938 |
Short Selling Information
The latest short interest is 11.06 million, so 17.42% of the outstanding shares have been sold short.
| Short Interest | 11.06M |
| Short Previous Month | 10.32M |
| Short % of Shares Out | 17.42% |
| Short % of Float | 20.03% |
| Short Ratio (days to cover) | 10.59 |
Income Statement
In the last 12 months, CDMO had revenue of $136.74 million and -$17.98 million in losses. Loss per share was -$0.28.
| Revenue | 136.74M |
| Gross Profit | 10.21M |
| Operating Income | -16.55M |
| Pretax Income | -21.15M |
| Net Income | -17.98M |
| EBITDA | -7.83M |
| EBIT | -17.96M |
| Loss Per Share | -$0.28 |
Balance Sheet
The company has $30.71 million in cash and $194.90 million in debt, giving a net cash position of -$164.19 million or -$2.59 per share.
| Cash & Cash Equivalents | 30.71M |
| Total Debt | 194.90M |
| Net Cash | -164.19M |
| Net Cash Per Share | -$2.59 |
| Equity / Book Value | 180.17M |
| Book Value Per Share | 2.84 |
| Working Capital | -119.30M |
Cash Flow
In the last 12 months, operating cash flow was $12.84 million and capital expenditures -$51.34 million, giving a free cash flow of -$38.50 million.
| Operating Cash Flow | 12.84M |
| Capital Expenditures | -51.34M |
| Free Cash Flow | -38.50M |
| FCF Per Share | -$0.61 |
Margins
Gross margin is 7.47%, with operating and profit margins of -12.11% and -13.15%.
| Gross Margin | 7.47% |
| Operating Margin | -12.11% |
| Pretax Margin | -15.47% |
| Profit Margin | -13.15% |
| EBITDA Margin | -5.73% |
| EBIT Margin | -13.14% |
| FCF Margin | -28.15% |
Dividends & Yields
CDMO does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | 1 |
| Payout Ratio | n/a |
| Buyback Yield | 8.45% |
| Shareholder Yield | 8.45% |
| Earnings Yield | -3.11% |
| FCF Yield | -6.65% |
Analyst Forecast
The average price target for CDMO is $12.50, which is 37.29% higher than the current price. The consensus rating is "Buy".
| Price Target | $12.50 |
| Price Target Difference | 37.29% |
| Analyst Consensus | Buy |
| Analyst Count | 5 |
| Revenue Growth Forecast (5Y) | 29.41% |
| EPS Growth Forecast (5Y) | n/a |
Stock Splits
The last stock split was on July 10, 2017. It was a reverse split with a ratio of 1:7.
| Last Split Date | Jul 10, 2017 |
| Split Type | Reverse |
| Split Ratio | 1:7 |
Scores
CDMO has an Altman Z-Score of -0.26 and a Piotroski F-Score of 3. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -0.26 |
| Piotroski F-Score | 3 |